Rohrer L, Raulf F, Bruns C, Buettner R, Hofstaedter F, Schüle R
Preclinical Research, Sandoz Pharma, Ltd., Basel, Switzerland.
Proc Natl Acad Sci U S A. 1993 May 1;90(9):4196-200. doi: 10.1073/pnas.90.9.4196.
We have isolated a gene coding for a fourth human somatostatin (somatotropin release-inhibiting factor) receptor. This additional somatostatin receptor (hSSTR4) is specifically expressed in human fetal and adult brain and lung tissue. The deduced amino acid sequence of the receptor displays both sequence and structural homology to three cloned somatostatin receptors as well as to other members of the family of GTP-binding-protein-coupled seven-helix transmembrane-spanning receptors. Pharmacological characterization of the expressed receptor reveals specific, high-affinity binding of somatostatin 14 and somatostatin 28. Surprisingly, several well-characterized synthetic somatostatin analogs fail to exhibit high-affinity binding to hSSTR4, indicating the existence of pharmacologically different receptor subtypes. Our data suggest that the diverse biological effects exerted by somatostatin are mediated by a family of receptors with discrete patterns of expression and different pharmacological properties.
我们分离出了一个编码第四种人类生长抑素(促生长激素释放抑制因子)受体的基因。这种额外的生长抑素受体(hSSTR4)在人类胎儿及成人的脑和肺组织中特异性表达。该受体推导的氨基酸序列与三个克隆的生长抑素受体以及GTP结合蛋白偶联的七螺旋跨膜受体家族的其他成员均显示出序列和结构同源性。对表达的受体进行药理学特性分析,结果显示生长抑素14和生长抑素28具有特异性、高亲和力结合。令人惊讶的是,几种特征明确的合成生长抑素类似物未能表现出与hSSTR4的高亲和力结合,这表明存在药理学上不同的受体亚型。我们的数据表明,生长抑素发挥的多种生物学效应是由一组具有不同表达模式和不同药理学特性的受体介导的。